MedTrace Logo

Glucocorticosteroid Therapy on Drug-induced Liver Injury: a Prospective Non-randomized Concurrent Control Trial

NCT04553003 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2022-04-29

No results posted yet for this study

Summary

The purpose of this study is to assess the safety and efficacy of glucocorticosteroid for treatment of drug-induced liver injury.

Conditions

  • Drug-induced Liver Injury

Interventions

DRUG

Glucocorticoids+hepatoprotectant

Participants received glucocorticoids (0.4mg/kg/d po.) and hepatoprotectant for 7 days.

DRUG

hepatoprotectant

Participants received hepatoprotectants (i.v.gtt.) for 7 days.

Sponsors & Collaborators

  • Li Yang

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-08-01
Primary Completion
2025-04-01
Completion
2025-04-01

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04553003 on ClinicalTrials.gov